/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the presentation of new investigational...

Related Keywords

United States , Malaysia , Tokyo , Japan , Tianjin , China , United Kingdom , Texas , Stanford , Illinois , Boston , Massachusetts , Russia , Thailand , Northwestern University , Singapore , Houston , Peking , Beijing , Northbrook , Chicago , Chinese , American , Jessicak Altman , Itsuro Nagase , Kenji Yasukawa , Philip Connor , Ahsan Arozullah , Jianxiang Wang , Lori Muffly , Thomas Leblanc , Greg Vercellotti , Eunices Wang , Erhan Berrak , Mo Zhou , Key Laboratory Of Experimental Hematology , Duke University School Of Medicine , Genentech , Astellas Pharma Us Inc , Institute Of Hematology , Kotobuki Pharmaceutical Co Ltd , American Society Of Hematology , Astellas Pharma Inc , Department Of Leukemia , Roberth Lurie Comprehensive Cancer Center , University Of Minnesota , Department Of Pediatric Hematology Oncology , Department Of Medicine , Division Of Hematology , American Cancer Society , Union Medical College , Roswell Park Comprehensive Cancer Center , Leukemia Group , University Of Texas Md Anderson Cancer Center , Division Of Blood , Analysis Group , Chinese Academy Of Medical Sciences , Feinberg School Of Medicine , Stanford University , Astellas Pharma , American Society , Annual Meeting , Vice President , Medical Sciences Oncology , Medical Affairs , Primary Focus Lead , Mitochondrial Biology , Duke University School , State Key Laboratory , Experimental Hematology , Blood Diseases Hospital , Chinese Academy , Medical Sciences , Peking Union Medical College , Gilteritinib Demonstrates Molecular Clearance , Acute Myeloid Leukemia , Naval Daver , Cancer Center , Ark Children , Marrow Transplantation , Comprehensive Cancer Center , Feinberg School , Real World Use , Kinase Inhibitors , Positive Acute Myeloid Leukemia , Prescribing Information , Focus Area Approach , Primary Focus Mitochondria , Primary Focus Mitochondria Biology , Astella Focus Area Approach , What Is Acute Myeloid Leukemia , Key Statistics , Eurj Cancer ,